Capricor Therapeutics
CAPR
$6.20
Share price
9.93%
Change (1 day)
42.53%
Change (1 year)
Categories
Earnings for Capricor Therapeutics (CAPR)
Earnings in 2023 (TTM): -$22.29 M
According to Capricor Therapeutics 's latest financial reports the company's current earnings (TTM) are -$22.29 M. In 2022 the company made an earning of -$29.02 M a decrease over its 2021 earnings that were of -$20.03 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Capricor Therapeutics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$22.29 M | -23.2% |
| 2022 | -$29.02 M | 44.93% |
| 2021 | -$20.03 M | 46.61% |
| 2020 | -$13.66 M | 78.71% |
| 2019 | -$7.65 M | -49.7% |
| 2018 | -$15.2 M | -724.78% |
| 2017 | $2.43 M | -112.93% |
| 2016 | -$18.81 M | 46.27% |
| 2015 | -$12.86 M | 106.82% |
| 2014 | -$6.22 M | -48.41% |
| 2013 | -$12.06 M | 977.23% |
| 2012 | -$1.12 M | -77.11% |
| 2011 | -$4.89 M | -22.35% |
| 2010 | -$6.3 M | -20.17% |
| 2009 | -$7.89 M | -41.17% |
| 2008 | -$13.4 M | 41.05% |
| 2007 | -$9.51 M | 1098.87% |
| 2006 | -$0.8 M | 4101.55% |
| 2005 | -$0.02 M | -0.97% |
| 2004 | -$0.02 M | 17.87% |
| 2003 | -$0.02 M | 3.66% |
| 2002 | -$0.02 M | -30.11% |
| 2001 | -$0.03 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -95,951.93% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $0.47 B | -2,229.89% | 🇺🇸 USA |
 Cytokinetics
CYTK | -$0.53 B | 2,261.16% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$0.15 B | 537.32% | 🇺🇸 USA |
 Palatin Technologies PTN | -$31.58 M | 41.68% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$20.53 M | -7.93% | 🇺🇸 USA |